Toshihiro Nukiwa

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations

Medicine, Oncology, Pharmacology +13

Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

Yoichiro Mitsuishi, Keiko Taguchi, Yukie Kawatani et al. · Cancer Cell · 2012 · 1.4K citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +16

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 954 citations

Medicine, Pharmacotherapy, Exercise Testing +15

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 636 citations · Full text

Medicine, Oncology, Pharmacology +12

First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui et al. · Journal of Clinical Oncology · 2009 · 516 citations

Medicine, Oncology, Pharmacology +13